At the news
? BEARISHIMPACT 6/10 EFFECT filed Aug 13, 2026 at 00:15 ET
Curis Inc.'s S-1 registration statement (File No. 333-298203) was declared effective by the SEC on August 12, 2026, under the 1933 Act. This allows the company to proceed with a securities offering, which for a micro-cap biotech with a $5M market cap is likely a dilutive follow-on or at-the-market offering. The effectiveness creates immediate dilution overhang for existing common shareholders, as the company can now sell shares to raise capital.
- SEC declared effective Curis Inc.'s S-1 registration statement (File No. 333-298203) on August 12, 2026.
- The effectiveness allows Curis to sell securities under the 1933 Act, typically a dilutive follow-on offering for a micro-cap biotech.
- Curis has a market capitalization of approximately $5M, making any new share issuance materially dilutive.
- The company is a clinical-stage biotech (SIC 2836) with no disclosed revenue or product sales in the filing.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access